株探米国株
日本語 英語
エドガーで原本を確認する
false 0000095574 0000095574 2024-03-13 2024-03-13
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)           March 13, 2024
 
Superior Group of Companies, Inc.
 
(Exact name of registrant as specified in its charter)
 
Florida
001-05869
11-1385670
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
   
200 Central Avenue, Suite 2000, St. Petersburg, Florida
(Address of principal executive offices)
33701
(Zip Code)
 
Registrant's telephone number including area code:                       (727) 397-9611
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230 .425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
SGC
NASDAQ
 






 
Item 2.02. Results of Operations and Financial Condition
 
The following information is being furnished under Item 2.02 of Form 8-K: Press release by Superior Group of Companies, Inc. (the “Company”) announcing its results of operations for the quarter ended December 31, 2023. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K.
 
 
Item 7.01. Regulation FD Disclosure
 
On March 13, 2024, the Company posted an investor presentation on its website. A copy of this presentation is attached as Exhibit 99.2 to this Form 8-K. 
 
The information furnished pursuant to Items 2.02 and 7.01 of this Form 8-K, including Exhibits 99.1 and 99.2 hereto, shall not be deemed "filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. 
 
 
Item 9.0l. Financial Statements and Exhibits
 
(d) Exhibits
 
Exhibit Number          Description
 
99.1                            Press Release, dated March 13, 2024
99.2                            Investor Presentation, dated March 2024
104                             Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.
 
 
SUPERIOR GROUP OF COMPANIES, INC.
 
 
 
By: /s/ Michael Koempel
Michael Koempel
Chief Financial Officer
 
 
 
Date: March 13, 2024
 
 
EX-99.1 2 ex_601124.htm EXHIBIT 99.1 ex_601124.htm

Exhibit 99.1

 

logo1.jpg
FOR IMMEDIATE RELEASE
A NASDAQ Listed Company: SGC  

 

 

SUPERIOR GROUP OF COMPANIES REPORTS FOURTH QUARTER RESULTS

 

– Total net sales of $147.2 million versus $148.6 million in prior year fourth quarter –
– Net income of $3.6 million versus net income of $2.2 million in prior year fourth quarter –
– EBITDA of $9.9 million versus adjusted $3.5 million in prior year fourth quarter –
– Provides full-year outlook –

 

ST. PETERSBURG, Fla. – March 13, 2024 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its fourth quarter 2023 results.

 

“We capped off 2023 with our best quarter of the year, delivering sequential improvement, stronger profitability and continued positive cash flow along with a substantially improved balance sheet,” said Michael Benstock, Chief Executive Officer. “Underlying fundamentals are moving in the right direction, consistent with what we saw through much of 2023. With our strong retention and new client wins, we are optimistic that we will continue to drive improved performance and consistently solid results. All three of our attractive end markets are growing and highly fragmented, and we believe our stronger financial position will enable us to take additional market share and enhance shareholder value in 2024 and beyond.” 

 

Fourth Quarter Results

 

For the fourth quarter ended December 31, 2023, net sales decreased 0.9% to $147.2 million compared to fourth quarter 2022 net sales of $148.6 million. Pretax income was $4.2 million compared to $1.2 million in the fourth quarter of 2022. Net income was $3.6 million or $0.22 per diluted share compared to $2.2 million or $0.14 per diluted share for the fourth quarter of 2022.

 

In the prior year fourth quarter, the Company realized a pre-tax, non-operating gain of $3.4 million. On an adjusted basis, which excludes the prior year’s pre-tax, non-operating gain, this quarter’s net income of $3.6 million or $0.22 per diluted share compares to a net loss of $0.9 million or $0.06 per diluted share for the prior year. At the conclusion of this press release is a reconciliation of reported to adjusted results, including a description of significant items.

 

2024 Full-Year Outlook

 

The Company is forecasting full year 2024 sales to be $558 million to $568 million versus 2023 sales of $543 million, and forecasting earnings per share to be $0.61 to $0.68, compared to $0.54 diluted adjusted earnings per share in 2023. 

 

 

1

 

Webcast and Conference Call

 

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian Toll-Free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through March 27, 2024. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 2106897 for replay access.

 

Disclosure Regarding Forward Looking Statements

 

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short-term and long-term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations, and (4) statements of expected industry and general economic trends.

 

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to supply disruptions, inflationary environment (including with respect to the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (“U.S.” or “United States”) in which the Company’s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Company’s material weakness in internal control over financial reporting; the Company’s ability to successfully remediate its material weakness in internal control over financial reporting and to maintain effective internal control over financial reporting; and other factors described in the Company’s filings with the Securities and Exchange Commission, including those described in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

 

About Superior Group of Companies, Inc. (SGC):

 

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

 

Investor Relations Contact:

 

Investors@Superiorgroupofcompanies.com

 

2

 

Comparative figures are as follows:

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except shares and per share data)

 

   

Three Months Ended December 31,

   

Years Ended December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Net sales

  $ 147,241     $ 148,613     $ 543,302     $ 578,831  
                                 

Costs and expenses:

                               

Cost of goods sold

    91,596       103,805       339,755       385,472  

Selling and administrative expenses

    49,198       44,322       183,205       176,320  

Goodwill impairment charge

    -       -       -       45,918  

Intangible assets impairment charge

    -       -       -       5,581  

Other periodic pension costs

    213       532       855       2,116  

Interest expense

    2,060       2,218       9,718       4,894  
      143,067       150,877       533,533       620,301  

Gain on sale of property, plant and equipment

    -       3,435       -       3,435  

Income (loss) before income tax expense

    4,174       1,171       9,769       (38,035 )

Income tax expense (benefit)

    617       (1,023 )     997       (6,065 )

Net income (loss)

  $ 3,557     $ 2,194     $ 8,772     $ (31,970 )
                                 

Net income (loss) per share:

                               

Basic

  $ 0.22     $ 0.14     $ 0.55     $ (2.03 )

Diluted

  $ 0.22     $ 0.14     $ 0.54     $ (2.03 )
                                 

Weighted average shares outstanding during the period:

                               

Basic

    16,010,006       15,841,296       15,968,199       15,764,859  

Diluted

    16,238,736       16,075,494       16,159,308       15,764,859  
                                 

Cash dividends per common share

  $ 0.14     $ 0.14     $ 0.56     $ 0.54  

 

3

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and par value data)

 

   

December 31,

 
   

2023

   

2022

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 19,896     $ 17,722  

Accounts receivable, less allowance for doubtful accounts of $4,237 and $7,622, respectively

    103,494       104,813  

Accounts receivable - other

    307       3,326  

Inventories

    98,067       124,976  

Contract assets

    48,715       52,980  

Prepaid expenses and other current assets

    8,881       14,166  

Total current assets

    279,360       317,983  

Property, plant and equipment, net

    46,890       51,392  

Operating lease right-of-use assets

    17,909       9,113  

Deferred tax asset

    12,356       10,718  

Intangible assets, net

    51,160       55,753  

Other assets

    14,775       11,982  

Total assets

  $ 422,450     $ 456,941  
                 

LIABILITIES AND SHAREHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 50,520     $ 42,060  

Other current liabilities

    43,978       38,646  

Current portion of long-term debt

    4,688       3,750  

Current portion of acquisition-related contingent liabilities

    1,403       736  

Total current liabilities

    100,589       85,192  

Long-term debt

    88,789       151,567  

Long-term pension liability

    13,284       12,864  

Long-term acquisition-related contingent liabilities

    557       2,245  

Long-term operating lease liabilities

    12,809       3,936  

Other long-term liabilities

    8,784       8,538  

Total liabilities

    224,812       264,342  

Commitments and contingencies

               

Shareholders’ equity:

               

Preferred stock, $.001 par value - authorized 300,000 shares (none issued)

    -       -  

Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding - 16,564,712 and 16,376,683 shares, respectively

    16       16  

Additional paid-in capital

    77,443       72,615  

Retained earnings

    122,464       122,979  

Accumulated other comprehensive income (loss), net of tax:

               

Pensions

    (1,122 )     (1,113 )

Foreign currency translation adjustment

    (1,163 )     (1,898 )

Total shareholders’ equity

    197,638       192,599  

Total liabilities and shareholders’ equity

  $ 422,450     $ 456,941  

 

4

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

   

Years Ended December 31,

 
   

2023

   

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income (loss)

  $ 8,772     $ (31,970 )

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

               

Depreciation and amortization

    13,995       13,004  

Goodwill impairment charge

    -       45,918  

Intangible assets impairment charge

    -       5,581  

Inventory write-downs

    2,346       13,569  

Provision for bad debts - accounts receivable

    539       2,891  

Share-based compensation expense

    3,787       4,289  

Deferred income tax benefit

    (1,635 )     (12,352 )

Gain on sale of property, plant and equipment

    -       (3,435 )

Change in fair value of acquisition-related contingent liabilities

    (189 )     (450 )

Change in fair value of written put options

    489       (1,565 )

Changes in assets and liabilities, net of acquisition of businesses:

               

Accounts receivable

    1,051       680  

Accounts receivable - other

    3,019       1,347  

Contract assets

    4,310       (15,092 )

Inventories

    24,672       (15,898 )

Prepaid expenses and other current assets

    5,496       5,225  

Other assets

    (2,012 )     1,858  

Accounts payable and other current liabilities

    13,310       (14,614 )

Payment of acquisition-related contingent liabilities

    (279 )     (3,346 )

Long-term pension liability

    407       2,190  

Other long-term liabilities

    851       (434 )

Net cash provided by (used in) operating activities

    78,929       (2,604 )
                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Additions to property, plant and equipment

    (4,963 )     (11,018 )

Proceeds from disposals of property, plant and equipment

    -       4,795  

Acquisition of businesses

    -       (11,202 )

Other investments

    (545 )     -  

Net cash used in investing activities

    (5,508 )     (17,425 )
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Proceeds from borrowings of debt

    6,000       332,143  

Repayment of debt

    (67,750 )     (292,773 )

Debt issuance costs

    (300 )     (869 )

Payment of cash dividends

    (9,188 )     (8,653 )

Payment of acquisition-related contingent liabilities

    (553 )     (1,416 )

Proceeds received on exercise of stock options

    175       728  

Tax withholdings on vesting of restricted shares and performance based shares and on exercise of stock rights

    -       (314 )

Net cash provided by (used in) financing activities

    (71,616 )     28,846  
                 

Effect of currency exchange rates on cash

    369       (30 )

Net increase in cash and cash equivalents

    2,174       8,787  

Cash and cash equivalents balance, beginning of year

    17,722       8,935  

Cash and cash equivalents balance, end of year

  $ 19,896     $ 17,722  

 

5

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands, except shares and per share data)

 

   

Three Months Ended December 31,

   

Years Ended December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Net income (loss)

  $ 3,557     $ 2,194     $ 8,772     $ (31,970 )

Interest expense

    2,060       2,218       9,718       4,894  

Income tax expense (benefit)

    617       (1,023 )     997       (6,065 )

Depreciation and amortization

    3,664       3,500       13,995       13,004  

Goodwill impairment charge

    -       -       -       45,918  

Intangible assets impairment charge

    -       -       -       5,581  

Gain on sale of property, plant and equipment

    -       (3,435 )     -       (3,435 )

Adjusted EBITDA(1)

  $ 9,898     $ 3,454     $ 33,482     $ 27,927  
                                 

Net income (loss)

  $ 3,557     $ 2,194     $ 8,772     $ (31,970 )

Adjustment for items:

                               

Goodwill impairment charge

    -       -       -       45,918  

Intangible assets impairment charge

    -       -       -       5,581  

Gain on sale of property, plant and equipment

    -       (3,435 )     -       (3,435 )

Tax impact of adjustments(2)

    -       324       -       (6,061 )

Adjusted net income (loss)(3)

  $ 3,557     $ (917 )   $ 8,772     $ 10,033  
                                 

Diluted net income (loss) per share

  $ 0.22     $ 0.14     $ 0.54     $ (2.03 )

Adjustment for items, after-tax, per diluted share

    -       (0.20 )     -       2.65  

Diluted adjusted net income (loss) per share(3)

  $ 0.22     $ (0.06 )   $ 0.54     $ 0.62  
                                 

Weighted average shares outstanding during the period:

                               

Diluted, as reported

    16,238,736       16,075,494       16,159,308       15,764,859  

Diluted, as adjusted(4)

    16,238,736       15,841,296       16,159,308       16,165,240  

 

(1) Adjusted EBITDA, which is a non-GAAP financial measure, is defined as net income (loss) excluding interest expense, income tax expense, depreciation and amortization expense, impairment charges and the other items described in the following sentence. The Company believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences, (iii) asset base (depreciation and amortization), (iv) the non-cash charges from asset impairments and (v) gains or losses on the sale of property, plant and equipment. The Company uses Adjusted EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used Adjusted EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered in isolation or as an alternative to net income (loss), cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted EBITDA are significant components in understanding and assessing the Company’s results of operations. The presentation of the Company’s Adjusted EBITDA may change from time to time, including as a result of changed business conditions, new accounting pronouncements or otherwise. If the presentation changes, the Company undertakes to disclose any change between periods and the reasons underlying that change. The Company’s Adjusted EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate Adjusted EBITDA in the same manner.

 

(2) The tax impact of adjustments includes the tax effect of each separate adjustment based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible, and the tax effect of items that relate to tax specific financial transactions.

 

(3) Adjusted net income (loss) and diluted adjusted net income (loss) per share, which are non-GAAP measures, are defined as net income (loss) and net income (loss) per share, excluding the impacts of impairment charges and gains or losses on the sale of property, plant and equipment. Management believes adjusted net income (loss) and diluted adjusted net income (loss) per share provides useful information to investors because it allows management, investors and others to evaluate and compare our operating results from period to period by removing the impact of impairment charges and gains or losses on the sale of property, plant and equipment that are not reflective of our core business.

 

(4) Diluted weighted average shares outstanding used to calculate diluted adjusted net loss per share excludes shares of common stock of 234,198 for the three months ended December 31, 2022, as the Company recognized an adjusted net loss and their inclusion would have been antidilutive. Diluted weighted average shares outstanding used to calculate diluted adjusted net income per share includes shares of common stock of 400,381 for the year ended December 31, 2022. These shares were excluded from diluted weighted average shares outstanding used to calculate diluted net income (loss) per share, as the Company recognized a net loss and their inclusion would have been antidilutive. 

 

6

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS

(Unaudited)

(In thousands)

 

   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Year Ended December 31, 2023:

                                               

Net sales

  $ 342,680     $ 113,878     $ 91,500     $ (4,756 )   $ -     $ 543,302  

Cost of goods sold

    228,053       71,597       42,352       (2,247 )     -       339,755  

Gross margin

    114,627       42,281       49,148       (2,509 )     -       203,547  

Selling and administrative expenses

    88,225       38,209       39,682       (2,509 )     19,598       183,205  

Other periodic pension cost

    -       -       -       -       855       855  

Add: Depreciation and amortization

    6,744       3,925       2,942       -       384       13,995  

Segment Adjusted EBITDA(1)

  $ 33,146     $ 7,997     $ 12,408     $ -     $ (20,069 )   $ 33,482  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Year Ended December 31, 2022:

                                               

Net sales

  $ 387,931     $ 113,321     $ 84,218     $ (6,639 )   $ -     $ 578,831  

Cost of goods sold

    273,134       80,719       34,439       (2,820 )     -       385,472  

Gross margin

    114,797       32,602       49,779       (3,819 )     -       193,359  

Selling and administrative expenses

    90,118       39,295       33,631       (3,819 )     17,095       176,320  

Other periodic pension cost

    -       -       -       -       2,116       2,116  

Add: Depreciation and amortization

    6,465       3,946       2,373       -       220       13,004  

Segment Adjusted EBITDA(1)

  $ 31,144     $ (2,747 )   $ 18,521     $ -     $ (18,991 )   $ 27,927  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended December 31, 2023:

                                               

Net sales

  $ 97,725     $ 28,003     $ 22,565     $ (1,052 )   $ -     $ 147,241  

Cost of goods sold

    63,561       17,725       10,807       (497 )     -       91,596  

Gross margin

    34,164       10,278       11,758       (555 )     -       55,645  

Selling and administrative expenses

    24,392       9,748       10,180       (555 )     5,433       49,198  

Other periodic pension cost

    -       -       -       -       213       213  

Add: Depreciation and amortization

    1,918       911       732       -       103       3,664  

Segment Adjusted EBITDA(1)

  $ 11,690     $ 1,441     $ 2,310     $ -     $ (5,543 )   $ 9,898  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended December 31, 2022:

                                               

Net sales

  $ 102,040     $ 26,426     $ 21,415     $ (1,268 )   $ -     $ 148,613  

Cost of goods sold

    70,712       24,653       9,001       (561 )     -       103,805  

Gross margin

    31,328       1,773       12,414       (707 )     -       44,808  

Selling and administrative expenses

    22,300       9,246       9,337       (707 )     4,146       44,322  

Other periodic pension cost

    -       -       -       -       532       532  

Add: Depreciation and amortization

    1,769       1,004       676       -       51       3,500  

Segment Adjusted EBITDA(1)

  $ 10,797     $ (6,469 )   $ 3,753     $ -     $ (4,627 )   $ 3,454  

 

(1) Segment Adjusted EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income (loss) before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and the other items not tied to the operational performance of the segment. Total Segment Adjusted EBITDA is a non-GAAP financial measure. Please see reconciliation of Adjusted EBITDA included in the Non-GAAP Financial Measures table above.

 

7
EX-99.2 3 ex_601125.htm EXHIBIT 99.2 Image Exhibit

Exhibit 99.2

 

 

slide01.jpg

 

 



slide02.jpg

 



slide03.jpg

 



slide04.jpg

 



slide05.jpg

 



slide06.jpg

 



slide07.jpg

 



slide08.jpg

 



slide09.jpg

 



slide10.jpg

 



slide11.jpg

 



slide12.jpg

 



slide13.jpg

 



slide14.jpg

 



slide15.jpg

 



slide16.jpg

 



slide17.jpg

 



slide18.jpg

 



slide19.jpg

 



slide20.jpg

 



slide21.jpg

 



slide22.jpg

 



slide23.jpg